Chung, Y., Lin, Y., Hung, M., Ho, M., & Fang, Y. (2022). Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer. OncoTargets & Therapy, 15, 1563. https://doi.org/10.2147/OTT.S386807
Chicago Style (17th ed.) CitationChung, Ying-Shan, Yu-Ching Lin, Ming-Szu Hung, Meng-Chin Ho, and Yu-Hung Fang. "Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides Difficile Infection Among Patients with Lung Cancer." OncoTargets & Therapy 15 (2022): 1563. https://doi.org/10.2147/OTT.S386807.
MLA (9th ed.) CitationChung, Ying-Shan, et al. "Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides Difficile Infection Among Patients with Lung Cancer." OncoTargets & Therapy, vol. 15, 2022, p. 1563, https://doi.org/10.2147/OTT.S386807.